AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson's Disease GlobeNewswire December 11, 2025 AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson's Disease Results show, for the first time, that targeting underlying a-syn pathology with an active immunotherapy could slow […]

Viasat Rocket Telemetry Service Selected by INNOSPACE for First Ever Commercial Launch from Brazil

Viasat Rocket Telemetry Service Selected by INNOSPACE for First Ever Commercial Launch from Brazil GlobeNewswire December 11, 2025 Korean launch provider INNOSPACE has selected Viasat's rocket telemetry service for its first ever commercial launch. It will also mark the first time this service will be used in a commercial mission carrying satellite payloads. LONDON, Dec.

Nevada Lithium Announces Winter Work Program Focused on Further Enhancing Value of the Bonnie Claire Lithium & Boron Project

Nevada Lithium Announces Winter Work Program Focused on Further Enhancing Value of the Bonnie Claire Lithium & Boron Project GlobeNewswire December 11, 2025 VANCOUVER, British Columbia, Dec. 11, 2025 (GLOBE NEWSWIRE) — Nevada Lithium Resources Inc. (TSXV: NVLH; OTCQB: NVLHF; FSE: 87K) (“Nevada Lithium” or the “Company“) is pleased to announce that it has commenced

BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025

BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025 GlobeNewswire December 11, 2025 In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed

iHerb CEO Emun Zabihi Named Among Top 10 CEOs Transforming Healthcare

iHerb CEO Emun Zabihi Named Among Top 10 CEOs Transforming Healthcare Annual List Published by The CEO Forum Group Recognizes Zabihi's Visionary Leadership in Advancing Global Wellness GlobeNewswire December 11, 2025 IRVINE, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — iHerb, one of the world's largest online retailers specializing in health and wellness, today announced that

Aircraft Electrical Systems Market worth $110.40 billion by 2030 – Exclusive Report by MarketsandMarkets™

According to MarketsandMarkets™, theAircraft Electrical Systems Marketis projected to grow from USD 94.06 billion in 2025 to USD 110.40 billion by 2030, registering a CAGR of 3.3% during the forecast period. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg Browse 220 market data Tables and 110 Figures spread through 300 Pages and in-depth TOC on 'Aircraft Electrical Systems Market – Global Forecast

eMerge Americas Announces First 2026 eMerge Americas Keynote Speakers

Tim Tebow, Dr. Alex Oshmyansky and Col. (Ret.) Nicole Malachowski confirmed for 2026 eMerge Americas global tech conference and expo in April eMerge Americas announced the first keynote speakers confirmed for the 12th annual eMerge Americas Conference + Expo, the premier global technology conference and expo shaping the future of tech, taking place April 22-24,

Suncor Energie annonce les perspectives de la Societe pour 2026

Tous les montants sont en dollars canadiens, à moins d’indication contraire Calgary, Alberta–(Newsfile Corp. – 11 décembre 2025) – Perspectives qui renforcent l’engagement de la Société à offrir un rendement supérieur aux actionnaires Croissance de la production en amont et taux d’utilisation des raffineries supérieurs aux objectifs annoncés lors de la Journée des investisseurs de

Suncor Energy announces 2026 corporate guidance

All financial figures are in Canadian dollars, unless noted otherwise Calgary, Alberta–(Newsfile Corp. – December 11, 2025) – Guidance reinforces company’s commitment to delivering superior shareholder returns Upstream production growth and refining utilization above 2024 Investor Day targets for 2026 Continued capital discipline with select high-quality strategic investments Increased share repurchases of $275 million per

Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial

In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of their body weight at 68 weeks Retatrutide reducedWOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function, with more than 1 out of 8 retatrutide-treated patients completely free

Scroll to Top